These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2423184

  • 1. The localization and characterization of substance P and substance K in striatonigral neurons.
    Lee JM, McLean S, Maggio JE, Zamir N, Roth RH, Eskay RL, Bannon MJ.
    Brain Res; 1986 Apr 16; 371(1):152-4. PubMed ID: 2423184
    [Abstract] [Full Text] [Related]

  • 2. Neurokinin A and substance P in striato-nigral neurons in rat brain.
    Lindefors N, Brodin E, Ungerstedt U.
    Neuropeptides; 1986 Apr 16; 8(2):127-32. PubMed ID: 2429229
    [Abstract] [Full Text] [Related]

  • 3. Regional distribution of substance P, neurokinin alpha and neurokinin beta in rat central nervous system.
    Kanazawa I, Ogawa T, Kimura S, Munekata E.
    Neurosci Res; 1984 Dec 16; 2(1-2):111-20. PubMed ID: 6085650
    [Abstract] [Full Text] [Related]

  • 4. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
    Bannon MJ, Lee JM, Giraud P, Young A, Affolter HU, Bonner TI.
    J Biol Chem; 1986 May 25; 261(15):6640-2. PubMed ID: 2422168
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ, Sivam SP, McGinty JF, Huang YS, Hong JS.
    J Pharmacol Exp Ther; 1987 Nov 25; 243(2):792-8. PubMed ID: 2445959
    [Abstract] [Full Text] [Related]

  • 6. Presence of substance P and GABA in separate striatonigral neurons.
    Gale K, Hong JS, Ghidotti A.
    Brain Res; 1977 Nov 11; 136(2):371-5. PubMed ID: 922491
    [No Abstract] [Full Text] [Related]

  • 7. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C, Knaus GA, Auer B, Knaus HG, Haring C, Theodorsson E, Saria A.
    Synapse; 1990 Nov 11; 6(1):1-9. PubMed ID: 1697986
    [Abstract] [Full Text] [Related]

  • 8. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
    Arai H, Emson PC.
    Brain Res; 1986 Dec 10; 399(2):240-9. PubMed ID: 2435360
    [Abstract] [Full Text] [Related]

  • 9. In vivo biosynthesis of [35S]- and [3H]substance P in the striatum of the rat and their axonal transport to the substantia nigra.
    Krause JE, Reiner AJ, Advis JP, McKelvy JF.
    J Neurosci; 1984 Mar 10; 4(3):775-85. PubMed ID: 6200582
    [Abstract] [Full Text] [Related]

  • 10. Distribution of substance K (neurokinin A) in the brain and peripheral tissues of rats.
    Takano Y, Nagashima A, Masui H, Kuromizu K, Kamiya HO.
    Brain Res; 1986 Mar 26; 369(1-2):400-4. PubMed ID: 2421847
    [Abstract] [Full Text] [Related]

  • 11. Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain.
    Kanazawa I, Emson PC, Cuello AC.
    Brain Res; 1977 Jan 07; 119(2):447-53. PubMed ID: 830395
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment.
    Hanson GR, Letter AA, Merchant K, Gibb JW.
    Peptides; 1986 Jan 07; 7(6):983-7. PubMed ID: 2436197
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the substance P- and dynorphin-containing projections to the substantia nigra: a radioimmunocytochemical and biochemical study.
    McLean S, Bannon MJ, Zamir N, Pert CB.
    Brain Res; 1985 Dec 30; 361(1-2):185-92. PubMed ID: 2417661
    [Abstract] [Full Text] [Related]

  • 14. Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment.
    Ritter JK, Schmidt CJ, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1984 May 30; 229(2):487-92. PubMed ID: 6201607
    [Abstract] [Full Text] [Related]

  • 15. Subcellular distribution of mammalian tachykinins in rat basal ganglia.
    Diez-Guerra FJ, Richardson PJ, Emson PC.
    J Neurochem; 1988 Feb 30; 50(2):440-50. PubMed ID: 2447239
    [Abstract] [Full Text] [Related]

  • 16. Evidence that neurokinin A (substance K) neurons project from the striatum to the substantia nigra in rats.
    Nagashima A, Takano Y, Masui H, Kamiya H.
    Neurosci Lett; 1987 Jun 01; 77(1):103-8. PubMed ID: 3037449
    [Abstract] [Full Text] [Related]

  • 17. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C, Saria A.
    Neurosci Lett; 1989 Oct 23; 105(1-2):159-63. PubMed ID: 2484728
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons.
    Nairn AC, Hemmings HC, Walaas SI, Greengard P.
    J Neurochem; 1988 Jan 23; 50(1):257-62. PubMed ID: 3335843
    [Abstract] [Full Text] [Related]

  • 20. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS, Hökfelt T, Herrera-Marschitz M, Håkanson R, Feng DM, Folkers K, Goldstein M, Ungerstedt U.
    Brain Res; 1990 Nov 05; 532(1-2):175-81. PubMed ID: 1704289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.